Integrative network analysis reveals time-dependent molecular events underlying left ventricular remodeling in post-myocardial infarction patients.

[1]  Peter Gaudron,et al.  Progressive Left Ventricular Dysfunction and Remodeling After Myocardial Infarction Potential Mechanisms and Early Predictors , 1993, Circulation.

[2]  T. Ideker,et al.  Integrative approaches for finding modular structure in biological networks , 2013, Nature Reviews Genetics.

[3]  A. Barabasi,et al.  Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.

[4]  Leslie L. Clark,et al.  Specific Temporal Profile of Matrix Metalloproteinase Release Occurs in Patients After Myocardial Infarction: Relation to Left Ventricular Remodeling , 2006, Circulation.

[5]  Y. Horio,et al.  The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy , 2015, Annals of the New York Academy of Sciences.

[6]  M. Fertin,et al.  Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). , 2010, The American journal of cardiology.

[7]  C E Lipscomb,et al.  Medical Subject Headings (MeSH). , 2000, Bulletin of the Medical Library Association.

[8]  M. Cesaroni,et al.  Enhancers compete with a long non-coding RNA for regulation of the Kcnq1 domain , 2014, Nucleic acids research.

[9]  S. Anker,et al.  Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. , 2013, International journal of cardiology.

[10]  M. Fertin,et al.  Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). , 2012, Journal of Cardiology.

[11]  K. Dickstein,et al.  The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction. , 2009, The American journal of cardiology.

[12]  F. Zannad,et al.  Extracellular Matrix Turnover Biomarkers Predict Long-Term Left Ventricular Remodeling After Myocardial Infarction: Insights From the REVE-2 Study , 2013, Circulation. Heart failure.

[13]  M. Fertin,et al.  Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE‐2 study) , 2011, European journal of heart failure.

[14]  G. Lemesle,et al.  Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.

[15]  Cathy H. Wu,et al.  Integrative Computational and Experimental Approaches to Establish a Post-Myocardial Infarction Knowledge Map , 2014, PLoS Comput. Biol..

[16]  David S. Wishart,et al.  HMDB 3.0—The Human Metabolome Database in 2013 , 2012, Nucleic Acids Res..

[17]  N. Khaper,et al.  Inflammatory cytokines and postmyocardial infarction remodeling. , 2004, Circulation research.

[18]  Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. , 1994, Circulation.

[19]  Gang Feng,et al.  Disease Ontology: a backbone for disease semantic integration , 2011, Nucleic Acids Res..

[20]  C. Bauters,et al.  Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group). , 2006, The American journal of cardiology.

[21]  Christian Stolte,et al.  Comprehensive comparison of large-scale tissue expression datasets , 2015, bioRxiv.

[22]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[23]  E. Braunwald.  Biomarkers in heart failure. Preface. , 2009, Heart failure clinics.

[24]  P. Amouyel,et al.  Serum MMP-8: A Novel Indicator of Left Ventricular Remodeling and Cardiac Outcome in Patients after Acute Myocardial Infarction , 2013, PloS one.

[25]  P. Amouyel,et al.  Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction. , 2012, The American journal of cardiology.

[26]  Francisco Azuaje,et al.  Systems-Based Approaches to Cardiovascular Biomarker Discovery , 2012, Circulation. Cardiovascular genetics.

[27]  J. Loscalzo,et al.  The Emerging Paradigm of Network Medicine in the Study of Human Disease , 2012, Circulation research.

[28]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[29]  Francis G Spinale,et al.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. , 2007, Physiological reviews.

[30]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[31]  Philip Lijnzaad,et al.  The Ensembl genome database project , 2002, Nucleic Acids Res..